Cathie Wood, founder and CEO of ARK Investment Management LLC, defended the future of artificial intelligence investments while highlighting Tesla Inc. (NASDAQ:TSLA) as a cornerstone of technological innovation during a recent podcast appearance with SoFi's Head of Investment Strategy, Liz Thomas.
What Happened: Wood popularly known for leading ARK Innovation ETF (NYSE:ARKK) characterized Tesla as "the largest AI project on Earth," emphasizing AI's transformative potential across multiple sectors.
She particularly highlighted healthcare advancements, where AI's convergence with sequencing technologies could revolutionize cancer diagnosis through blood testing, especially when combined with CRISPR gene editing capabilities.
Addressing concerns about heavy GPU and cloud infrastructure investments by major tech companies, Wood acknowledged investor skepticism about capital expenditure increases.
Wood cited Microsoft Corp's (NASDAQ:MSFT) dramatic spending surge from $30 billion to $60 billion in 18 months as an example of investments that have yet to demonstrate clear returns.
Why It Matters: The ARK Invest CEO's comments come amid her firm's recent portfolio adjustments, including an $18 million reduction in Tesla holdings through its flagship funds. Despite these sales, Wood maintains a bullish long-term outlook on Tesla's autonomous driving potential, projecting a "trillion-dollar-plus revenue opportunity."
Wood's investment thesis extends beyond Tesla to the broader biologics sector, where she envisions a $400 billion market opportunity emerging from the convergence of AI, genetic sequencing, and gene editing technologies.
Her ARK Genomic Revolution ETF (BATS:ARKG), managing $1.179 billion in assets, reflects this conviction through significant investments in companies like Twist Bioscience Corp. (NASDAQ:TWST) and CRISPR Therapeutics AG (NASDAQ:CRSP).
Responding to concerns about elevated market valuations, Wood noted that current market multiples in the low 20s leave little room for error. However, she remains confident in the emergence of transformational business models, particularly at the intersection of AI and healthcare innovation, where she sees potential for revolutionary advances in disease treatment and diagnosis.
- Meta, TikTok, Snapchat Could Face $32M Fines As Australia Enforces Social Media Ban For Under-16s
Image via Ark Invest
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
凯西·伍德，ark投资管理有限公司的创始人兼首席执行官，在最近与SoFi投资策略主管丽兹·托马斯的播客中辩护人工智能投资的未来，同时强调了特斯拉公司（纳斯达克：TSLA）作为技术创新的基石。
发生了什么：伍德因领导ark innovation etf（纽交所：ARKK）而广受欢迎，她将特斯拉称为“地球上最大的人工智能项目”，强调人工智能在多个板块的变革潜力。
她特别强调了医疗保健的进展，人工智能与测序技术的融合可以通过血液检测彻底改变癌症诊断，尤其是与CRISPR基因编辑能力结合时。
在应对主要科技公司对gpu和云基础建设投资的担忧时，伍德承认投资者对资本支出增加的怀疑。
伍德以微软公司（纳斯达克：MSFT）在18个月内从300亿到600亿的支出激增为例，引用了尚未显示出明确回报的投资。
为什么这很重要：ark的首席执行官的评论正值她的公司最近调整投资组合，包括通过其旗舰所有基金类型减少1800万美元的特斯拉持有。尽管进行了这些出售，伍德对特斯拉的自主驾驶潜力持看好的长期展望，预测有“超过一万亿美元的营业收入机会”。
伍德的投资论点超越了特斯拉，关注更广泛的生物制品板块，她设想人工智能、基因测序和基因编辑技术的融合将带来4000亿的市场机会。
她的ark生物基因科技革新主动型etf（BATS:ARKG）管理着11.79亿资产，通过对如Twist Bioscience Corp.（纳斯达克：TWST）和CRISPR Therapeutics AG（纳斯达克：CRSP）等公司的重要投资来体现这一信念。
针对市场估值过高的担忧，伍德指出，当前市场倍数在低20区间，几乎没有错误的余地。然而，她对变革性业务模式的出现仍然充满信心，特别是在人工智能与医疗创新交汇的领域，她看到在疾病治疗和诊断方面有革命性进展的潜力。
- Meta、TikTok、Snapchat可能面临3200万澳元的罚款，因为澳洲强制禁止16岁以下用户使用社交媒体。
图片来源于ark
免责声明：本内容部分由Benzinga Neuro帮助制作，并经Benzinga编辑审查和发布。
